The Cost of Capital: A Sceptic's View by Boyle, Glenn
Glenn Boyle
University of Otago and LECG
The Cost of Capital:
A Sceptic's View




A project's cost of capital is the expected
return available on a financial market
investment of equal risk
Principle II
This expected return can be estimated
using the Capital Asset Pricing Model
(CAPM)
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Features of The Textbook
Approach
• Only systematic risk matters
• Systematic risk = market risk
• Cost of capital for any project is the same
regardless of the firm that undertakes it
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Principle I
• New project cannot alter set of available
investment opportunities (Spanning)
• If it does, its introduction changes risk of
existing securities
• Then cannot use these securities to infer
risk of new project
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Spanning
• “(Without spanning), much of what is
taught on capital budgeting would go out
the window.” (Martin Weingartner, Journal
of Finance, 1977)
• Implication: Hope like hell that financial
markets are sufficiently deep and liquid
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Principle II: Non-market risk
• Only market risk matters if investors hold
market portfolio
• Portfolios that differ from the market
portfolio have significant non-market risk
• This risk can be related to various non-
market 'factors' (APT)
• But we don't know what these factors are
©GB 8-Aug-03 Slide 7
Market frictions
• Project with high non-market risk can weaken the firm's
financial position
• Weaker financial position can adversely affect other firm
projects
• Loss of value in other projects is an additional cost of the
new project
• "Only systematic risk matters" assumes financing is
unconstrained and costless, i.e., frictionless markets
– Then firm's financial position has no effect on cost of
project
• Implication: The greater a firm's non-market risk, the
higher the effective cost of capital
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Example: Catastrophe Reinsurance
• The volatility of returns on catastrophe
reinsurance are very high, but these risks are
diversifiable and thus should not command a risk
premium
• In 1996, Berkshire Hathaway agreed to sell
$1.05 billion of reinsurance to the California
Earthquake Authority
– Probability of BH having to pay anything = 1.7%
– Premium was $113 million (633% of the expected
loss!) vs TB premium of $17.85 million
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Timing Flexibility
• Most projects can be delayed and are at least
partly irreversible
• Firm holds an 'option' to invest at the 'best' date
• When investment begins, firm sacrifices option
• 'Loss' of option is an additional cost of project
• More non-market risk makes option more
valuable
• Implication: The greater a firm's non-market risk,
the higher the effective cost of capital
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Principle II: Evidence
• Firms hedge
• Firms seem to use discount rates far
exceeding the CAPM rate.
• Internal control premium?
– Not supported by survey evidence
– Why not adjust cash flows back down?
– Unsustainable equilibrium
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The CAPM
• CAPM can only explain at most 11% of
variation in NZ stock returns
• "Relying on the CAPM ... for cost of capital
calculations ... is dubious." (Bartholdy et
al, 1997)
©GB 8-Aug-03 Slide 12
Beta
• Betas reflect common variation in cashflows?
• “Lone prospectors in search of gold look forward to
extremely uncertain future earnings, but whether they
strike it rich is not likely to depend on the performance of
the market portfolio Therefore, an investment in gold has
a high standard deviation but a relatively low beta.”
(Brealey and Myers, 1991)
• Ignores common variation in expected returns (discount
rates)
• So have two sources of beta, each with different
premium
• Two-beta model works better
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Market Risk Premium
• Historical averaging unlikely to be
consistent with CAPM pricing process
• More general model (CCAPM) gives very
low estimates of equity premium
• But “You cannot adopt the CAPM on the
belief that the (CCAPM) is wrong. If you
think the (CCAPM) is fundamentally
wrong, the economic justification for the
CAPM evaporates as well.” (Cochrane,
2001)
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Conclusion
• Textbook model only a starting point
• But still searching for practical extensions
in most areas
